|
| 35982181 | Loss of KLK4::KLKP1 pseudogene expression by RNA chromogenic in-situ hybridization is associated with PTEN loss and increased risk of biochemical recurrence in a cohort of middle eastern men with prostate cancer. | J Cancer Res Clin Oncol | 2023 |
| 37025118 | Brief Report: Prognostic Relevance of 3q Amplification in Squamous Cell Carcinoma of the Lung. | JTO Clin Res Rep | 2023 |
| 34337539 | Decreased ATM Protein Expression Is Substantiated with PTEN Loss in Defining Aggressive Phenotype of Prostate Cancer Associated with Lethal Disease. | Eur Urol Open Sci | 2021 |
| 33547200 | Virus-positive Merkel Cell Carcinoma Is an Independent Prognostic Group with Distinct Predictive Biomarkers. | Clin Cancer Res | 2021 |
| 34493733 | Transcriptional network involving ERG and AR orchestrates Distal-less homeobox-1 mediated prostate cancer progression. | Nat Commun | 2021 |
| 34068856 | Copy Number Profiles of Prostate Cancer in Men of Middle Eastern Ancestry. | Cancers (Basel) | 2021 |
| 31437301 | A pediatric case of pigmented epithelioid melanocytoma with chromosomal copy number alterations in 15q and 17q and a novel NTRK3-SCAPER gene fusion. | J Cutan Pathol | 2020 |
| 34337483 | High Serine-arginine Protein Kinase 1 Expression with PTEN Loss Defines Aggressive Phenotype of Prostate Cancer Associated with Lethal Outcome and Decreased Overall Survival. | Eur Urol Open Sci | 2020 |
| 31672072 | Atypical Lipomatous Tumor/Well-Differentiated Liposarcoma With Features Mimicking Spindle Cell Lipoma. | Int J Surg Pathol | 2020 |
| 31959826 | Androgen deprivation upregulates SPINK1 expression and potentiates cellular plasticity in prostate cancer. | Nat Commun | 2020 |
| 31857679 | Next-generation sequencing implicates oncogenic roles for p53 and JAK/STAT signaling in microcystic adnexal carcinomas. | Mod Pathol | 2020 |
| 31947893 | High-Throughput Label-Free Isolation of Heterogeneous Circulating Tumor Cells and CTC Clusters from Non-Small-Cell Lung Cancer Patients. | Cancers (Basel) | 2020 |
| 32576626 | The MD Anderson Prostate Cancer Patient-derived Xenograft Series (MDA PCa PDX) Captures the Molecular Landscape of Prostate Cancer and Facilitates Marker-driven Therapy Development. | Clin Cancer Res | 2020 |
| 32639612 | Gene fusion characterisation of rare aggressive prostate cancer variants-adenosquamous carcinoma, pleomorphic giant-cell carcinoma, and sarcomatoid carcinoma: an analysis of 19 cases. | Histopathology | 2020 |
| 32238875 | Clonal evaluation of prostate cancer molecular heterogeneity in biopsy samples by dual immunohistochemistry and dual RNA in situ hybridization. | Mod Pathol | 2020 |
| 32350606 | Molecular characterization of prostate cancer in Middle Eastern population highlights differences with Western populations with prognostic implication. | J Cancer Res Clin Oncol | 2020 |
| 32231273 | Therapeutically actionable PAK4 is amplified, overexpressed, and involved in bladder cancer progression. | Oncogene | 2020 |
| 32192385 | A Novel <i>COL1A1-CAMTA1</i> Rearrangement in Cranial Fasciitis. | Int J Surg Pathol | 2020 |
| 31584209 | Clonal evaluation of early onset prostate cancer by expression profiling of ERG, SPINK1, ETV1, and ETV4 on whole-mount radical prostatectomy tissue. | Prostate | 2020 |
| 30587549 | Epigenetic Silencing of miRNA-338-5p and miRNA-421 Drives SPINK1-Positive Prostate Cancer. | Clin Cancer Res | 2019 |
| 31835700 | A Hierarchical Machine Learning Model to Discover Gleason Grade-Specific Biomarkers in Prostate Cancer. | Diagnostics (Basel) | 2019 |
| 30239030 | Neurofilament is superior to cytokeratin 20 in supporting cutaneous origin for neuroendocrine carcinoma. | Histopathology | 2019 |
| 31496918 | Eukaryotic Translation Initiation Factor 4 Gamma 1 (EIF4G1): a target for cancer therapeutic intervention? | Cancer Cell Int | 2019 |
| 31466944 | CDK7 Inhibition Suppresses Castration-Resistant Prostate Cancer through MED1 Inactivation. | Cancer Discov | 2019 |
| 31446281 | Pseudogene Associated Recurrent Gene Fusion in Prostate Cancer. | Neoplasia | 2019 |
| 31129769 | Combined loss of TFF3 and PTEN is associated with lethal outcome and overall survival in men with prostate cancer. | J Cancer Res Clin Oncol | 2019 |
| 30720899 | Prostate cancer with comedonecrosis is frequently, but not exclusively, intraductal carcinoma: a need for reappraisal of grading criteria. | Histopathology | 2019 |
| 29620284 | Enrichment and mutation detection of circulating tumor cells from blood samples. | Oncol Rep | 2018 |
| 30051493 | Wnt receptor Frizzled 8 is a target of ERG in prostate cancer. | Prostate | 2018 |
| 30101374 | Clinical utility of assessing PTEN and ERG protein expression in prostate cancer patients: a proposed method for risk stratification. | J Cancer Res Clin Oncol | 2018 |
| 30291535 | Association of ERG/PTEN status with biochemical recurrence after radical prostatectomy for clinically localized prostate cancer. | Med Oncol | 2018 |
| 29617048 | Pseudosarcomatous myofibroblastic proliferations of the genitourinary tract are genetically different from nodular fasciitis and lack USP6, ROS1 and ETV6 gene rearrangements. | Histopathology | 2018 |
| 29744932 | Expression and role of PAICS, a de novo purine biosynthetic gene in prostate cancer. | Prostate | 2018 |
| 27550065 | Expression and Role of PAICS, a De Novo Purine Biosynthetic Gene in Prostate Cancer. | Prostate | 2017 |
| 28731045 | Renal cell tumors with clear cell histology and intact VHL and chromosome 3p: a histological review of tumors from the Cancer Genome Atlas database. | Mod Pathol | 2017 |
| 28877055 | Solitary Fibrous Tumors of the Head and Neck: A Multi-Institutional Clinicopathologic Study. | Am J Surg Pathol | 2017 |
| 28716896 | Poor Prognosis Indicated by Venous Circulating Tumor Cell Clusters in Early-Stage Lung Cancers. | Cancer Res | 2017 |
| 28739498 | Increased expression of EZH2 in Merkel cell carcinoma is associated with disease progression and poorer prognosis. | Hum Pathol | 2017 |
| 28606924 | Age and Gender Associations of Virus Positivity in Merkel Cell Carcinoma Characterized Using a Novel RNA <i>In Situ</i> Hybridization Assay. | Clin Cancer Res | 2017 |
| 27793843 | HER2 and EGFR Overexpression Support Metastatic Progression of Prostate Cancer to Bone. | Cancer Res | 2017 |
| 28009604 | Renal Cell Carcinoma With Chromosome 6p Amplification Including the TFEB Gene: A Novel Mechanism of Tumor Pathogenesis? | Am J Surg Pathol | 2017 |
| 27790742 | The utility of ETV1, ETV4 and ETV5 RNA in-situ hybridization in the diagnosis of CIC-DUX sarcomas. | Histopathology | 2017 |
| 27864122 | Sclerosing TFEB-rearrangement renal cell carcinoma: a recurring histologic pattern. | Hum Pathol | 2017 |
| 27507192 | Expanded Circulating Tumor Cells from a Patient with ALK-Positive Lung Cancer Present with EML4-ALK Rearrangement Along with Resistance Mutation and Enable Drug Sensitivity Testing: A Case Study. | J Thorac Oncol | 2017 |
| 26725250 | SPINK1 expression in relation to PTEN and ERG in matched primary and lymph node metastatic prostate cancer: Implications for biomarker development. | Urol Oncol | 2016 |
| 29264192 | Cultured circulating tumor cells and their derived xenografts for personalized oncology. | Asian J Urol | 2016 |
| 26404914 | A subset of solitary fibrous tumors express nuclear PAX8 and PAX2: a potential diagnostic pitfall. | Histol Histopathol | 2016 |
| 27926866 | Inflammation-Induced Oxidative Stress Mediates Gene Fusion Formation in Prostate Cancer. | Cell Rep | 2016 |
| 27606879 | RNA-Binding Protein FXR1 Regulates p21 and TERC RNA to Bypass p53-Mediated Cellular Senescence in OSCC. | PLoS Genet | 2016 |
| 27783624 | Correction: RNA-Binding Protein FXR1 Regulates p21 and TERC RNA to Bypass p53-Mediated Cellular Senescence in OSCC. | PLoS Genet | 2016 |